IMPLEMENTATION OF SIGMA METRICS FOR EVALUATION OF ANALYTICAL QUALITY IN CLINICAL BIOCHEMISTRY LABORATORY OF A TERTIARY CARE HOSPITAL
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 21
Abstract
BACKGROUND Amelioration of analytical quality in clinical laboratories is recognised as an emerging concern worldwide. Quality has been described as conformance to the requirement of users and the satisfaction of their needs and expectations. Quality assurance is need of the hour in all sectors including laboratory service. Six sigma provides a general methodology to describe performance on sigma scale. The present study was undertaken to evaluate the quality of the analytical performance of clinical biochemistry laboratory with the help of sigma metrics. MATERIALS AND METHODS Internal quality control (QC) data for both levels of control, L1 (normal) and L2 (high) obtained from clinical biochemistry laboratory of College of Medicine and Sagore Dutta Hospital were analysed over a period of one year from July 2016 to July 2017. Laboratory mean, standard deviation(SD) and coefficient of variation (CV %) were calculated for parameters like sugar, urea, creatinine, triglyceride, cholesterol, High Density Lipoprotein (HDL), Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP), total protein, albumin and uric acid. Sigma factor was calculated using both levels of internal QC for the above-mentioned parameters. RESULTS Parameters such as ALP, Triglyceride (L2) and HDL with average sigma values (> 6) was considered as satisfactory. Parameters having average Sigma 3 - 6 relating to glucose, urea, creatinine (L2), ALT (L2), AST (L2), uric acid, Bilirubin total, Cholesterol (L1), Total protein and albumin were considered as acceptable, but needed close supervision. We got sigma < 3 for parameters like ALT (L1), AST (L1), Creatinine (L1) and Cholesterol (L2) which were unacceptable. CONCLUSION Sigma metrics thus calculated can be used as a guide for planning quality control strategy. The findings of our study will emphasise the need for evaluation of ongoing quality assurance programme and adoption of corrective and preventive measure. Ideal analytical methodology, quality control material and quality control strategy should be introduced to achieve uniform six sigma standards across all laboratories.
Authors and Affiliations
Jayati Roy Choudhury, Sayari Banerjee, Indranil Chakraborty
Keywords
Related Articles
- EP ID EP431605
- DOI 10.14260/jemds/2018/571
- Views 65
- Downloads 0
A COMPARATIVE STUDY OF ATTITUDES OF ADOLESCENTS STUDYING IN JUNIOR COLLEGES OF RURAL AND URBAN AREAS OF BIJAPUR TOWARDS EDUCATIONAL AND NUTRITIONAL ASPECTS OF LIFE
BACKGROUND Adolescent period is a time of considerable change in all aspect of functioning. There are three aspects of significant concern during adolescence, viz. educational change drastically due to rapid increase in...
COMPARISON BETWEEN TAMSULOSIN AND SILODOSIN IN LOWER URETERIC STONE- A RANDOMISED CONTROLLED STUDY
BACKGROUND 70% of ureteral stones are located in the lower third of the ureter. Medical expulsive therapy (MET) using adrenergic antagonists has recently emerged as an alternative strategy for the initial management of s...
REACTIVE MILIEU OF HODGKIN LYMPHOMA WITH EMPHASIS ON MAST CELLS AND MACROPHAGES
AIM OF STUDY To study the clinical importance of reactive microenvironment inHodgkin Lymphoma (HL) with special reference to macrophages and mast cells. MATERIALS AND METHODS The present prospective and retrosp...
ANTIBIOGRAM OF PREVALENT MICROORGANISMS IN WOUND INFECTIONS- A COMPARATIVE STUDY BETWEEN DIABETIC AND NON-DIABETIC PATIENTS ATTENDING A TERTIARY CARE HOSPITAL
BACKGROUND Management of wound infections is a challenge even today due to inadequate understanding of microbial pattern and therapeutic approaches. This study was thus designed to identify the isolates to study the anti...
STUDY ON CLINICAL PROFILE AND CAUSES OF HYPOKALAEMIC PERIODIC PARALYSIS
BACKGROUND Hypokalaemic Periodic Paralysis (HPP) is a Channelopathy which affects the musculoskeletal, nervous, endocrine or metabolic systems and is characterised by episodic skeletal muscular weakness and paralysis in...